Adamas Pharmaceuticals Inc·4

Apr 16, 4:42 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed Apr 16, 2015

Insider Transaction Report

Form 4
Period: 2015-04-15
Transactions
  • Sale

    Common Stock

    2015-04-15$17.72/sh1,000$17,72047,778 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_576731

    POA DOCUMENT